Page 27 - Read Online

Zhang et al. Hepatoma Res 2020;6:30 I http://dx.doi.org/10.20517/2394-5079.2020.17 Page 15 of 16

hepatitis B virus-related hepatocellular carcinoma. Diagn Interv Radiol 2018;24:121-7.
72. Xu X, Zhang HL, Liu QP, Sun SW, Zhang J, et al. Radiomic analysis of contrast-enhanced CT predicts microvascular invasion and
outcome in hepatocellular carcinoma. J Hepatol 2019;70:1133-44.
73. Ji GW, Zhu FP. Radiomic features at contrast-enhanced CT predict recurrence in early stage hepatocellular carcinoma: a multi-
institutional study. Radiology 2020;294:568-79.
74. Zhu YJ, Feng B, Wang S, Wang LM, Wu JF, et al. Model-based three-dimensional texture analysis of contrast-enhanced magnetic
resonance imaging as a potential tool for preoperative prediction of microvascular invasion in hepatocellular carcinoma. Oncol Lett
2019;18:720-32.
75. Kutami R, Nakashima Y, Nakashima O, Shiota K, Kojiro M. Pathomorphologic study on the mechanism of fatty change in small
hepatocellular carcinoma of humans. J Hepatol 2000;33:282-9.
76. Takayama T, Makuuchi M, Hirohashi S, Sakamoto M, Okazaki N, et al. Malignant transformation of adenomatous hyperplasia to
hepatocellular carcinoma. Lancet 1990;336:1150-3.
77. Villanueva A, Newell P, Chiang DY, Friedman SL, Llovet JM. Genomics and signaling pathways in hepatocellular carcinoma. Semin
Liver Dis 2007;27:55-76.
78. Asayama Y, Nishie A, Ishigami K, Ushijima Y, Takayama Y, et al. Fatty change in moderately and poorly differentiated hepatocellular
carcinoma on MRI: a possible mechanism related to decreased arterial flow. Clin Radiol 2016;71:1277-83.
79. Min JH, Kim YK, Lim S, Jeong WK, Choi D, et al. Prediction of microvascular invasion of hepatocellular carcinomas with gadoxetic
acid-enhanced MR imaging: Impact of intra-tumoral fat detected on chemical-shift images. Eur J Radiol 2015;84:1036-43.
80. Kubota N, Ojima H, Hatano M, Yamazaki K, Masugi Y, et al. Clinicopathological features of hepatocellular carcinoma with fatty change:
tumors with macrovesicular steatosis have better prognosis and aberrant expression patterns of perilipin and adipophilin. Pathol Int
2020;70:199-209.
81. Yamaguchi H, Condeelis J. Regulation of the actin cytoskeleton in cancer cell migration and invasion. Biochimica et biophysica acta
2007; 1773: 642-652.
82. Kim YY, Choi JY, Sirlin CB, An C, Kim MJ. Pitfalls and problems to be solved in the diagnostic CT/MRI Liver Imaging Reporting and
Data System (LI-RADS). Eur Radiol 2019;29:1124-32.
83. Qin S. Guidelines on the diagnosis and treatment of primary liver cancer (2011 edition). Chin Clin Oncol 2012;1:10.
84. Hennedige T, Venkatesh SK. Advances in computed tomography and magnetic resonance imaging of hepatocellular carcinoma. World J
Gastroenterol 2016;22:205-20.
85. Cheng S, Chen M, Cai J. Chinese expert consensus on multidisciplinary diagnosis and treatment of hepatocellular carcinoma with portal
vein tumor thrombus: 2016 edition. Oncotarget 2017;8:8867-76.
86. Ponziani FR, Zocco MA, Campanale C, Rinninella E, Tortora A, et al. Portal vein thrombosis: insight into physiopathology, diagnosis,
and treatment. World J Gastroenterol 2010;16:143-55.
87. Kanematsu M, Semelka RC, Leonardou P, Mastropasqua M, Lee JK. Hepatocellular carcinoma of diffuse type: MR imaging findings and
clinical manifestations. J Magn Reson Imaging 2003;18:189-95.
88. An J, Lee KS, Kim KM. Clinical features and outcomes of patients with hepatocellular carcinoma complicated with bile duct invasion.
Clin Mol Hepatol 2017;23:160-9.
89. Chotirosniramit A, Liwattanakun A, Lapisatepun W, Ko-Iam W, Sandhu T, et al. A single institution report of 19 hepatocellular carcinoma
patients with bile duct tumor thrombus. J Hepatocell Carcinoma 2017;4:41-7.
90. Suh YG, Kim DY, Han KH, Seong J. Effective biliary drainage and proper treatment improve outcomes of hepatocellular carcinoma with
obstructive jaundice. Gut Liver 2014;8:526-35.
91. Liu QY, Huang SQ, Chen JY, Li HG, Gao M, et al. Small hepatocellular carcinoma with bile duct tumor thrombi: CT and MRI findings.
Abdom Imaging 2010;35:537-42.
92. Lu CH, Chen CL, Cheng YF, Huang TL, Tsang LL, et al. Correlation between imaging and pathologic findings in explanted livers of
hepatocellular carcinoma cases. Transplant Proc 2010;42:830-3.
93. Liu Q, Chen J, Li H, Liang B, Zhang L, et al. Hepatocellular carcinoma with bile duct tumor thrombi: correlation of magnetic resonance
imaging features to histopathologic manifestations. Eur J Radiol 2010;76:103-9.
94. Giannelli G, Rani B, Dituri F, Cao Y, Palasciano G. Moving towards personalised therapy in patients with hepatocellular carcinoma: the
role of the microenvironment. Gut 2014;63:1668-76.
95. Ariizumi S, Kitagawa K, Kotera Y, Takahashi Y, Katagiri S, et al. A non-smooth tumor margin in the hepatobiliary phase of gadoxetic acid
disodium (Gd-EOB-DTPA)-enhanced magnetic resonance imaging predicts microscopic portal vein invasion, intrahepatic metastasis, and
early recurrence after hepatectomy in patients with hepatocellular carcinoma. J Hepatobiliary Pancreat Sci 2011;18:575-85.
18
96. Seo HJ, Kim GM, Kim JH, Kang WJ, Choi HJ. F-FDG PET/CT in hepatocellular carcinoma: detection of bone metastasis and
prediction of prognosis. Nucl Med Commun 2015;36:226-33.
97. Hwang SH, Lee JW, Cho HJ, Kim KS, Choi GH, et al. Prognostic value of metabolic tumor volume and total lesion glycolysis on
preoperative F-FDG PET/CT in patients with very early and early hepatocellular carcinoma. Clin Nucl Med 2017;42:34-9.
18
98. Ho CL, Chen S, Yeung DW, Cheng TK. Dual-tracer PET/CT imaging in evaluation of metastatic hepatocellular carcinoma. J Nucl Med
2007;48:902-9.
99. Kitao A, Matsui O, Yoneda N, Kozaka K, Kobayashi S, et al. Hepatocellular carcinoma with β-catenin mutation: Imaging and pathologic
characteristics. Radiology 2015;275:708-17.
100. Zucman-Rossi J, Jeannot E, Nhieu JT, Scoazec JY, Guettier C, et al. Genotype-phenotype correlation in hepatocellular adenoma: new